Alexion and Verge enter AI-powered drug discovery deal
Alexion has entered into a partnership with Verge Genomics to detect new drug targets for rare neurodegenerative and neuromuscular ailments.
Alexion has entered into a partnership with Verge Genomics to detect new drug targets for rare neurodegenerative and neuromuscular ailments.
What's Your Reaction?
